These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16242130)

  • 1. Assembly of major histocompatibility complex class II subunits with invariant chain.
    Neumann J; Koch N
    FEBS Lett; 2005 Nov; 579(27):6055-9. PubMed ID: 16242130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.
    Neumann J; Koch N
    J Cell Sci; 2006 Oct; 119(Pt 20):4207-14. PubMed ID: 16984974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
    Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
    J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant chain influences post-translational processing of HLA-DR molecules.
    Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
    J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of an abundant endogenous major histocompatibility complex class II/peptide complex in class II compartments.
    Morkowski S; Raposo G; Kleijimeer M; Geuze HJ; Rudensky AY
    Eur J Immunol; 1997 Mar; 27(3):609-17. PubMed ID: 9079799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
    Lamb CA; Cresswell P
    J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invariant chain can bind MHC class II at a site other than the peptide binding groove.
    Wilson NA; Wolf P; Ploegh H; Ignatowicz L; Kappler J; Marrack P
    J Immunol; 1998 Nov; 161(9):4777-84. PubMed ID: 9794409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
    Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
    J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
    Khalil H; Brunet A; Thibodeau J
    J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
    Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
    Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.
    Temme S; Zacharias M; Neumann J; Wohlfromm S; König A; Temme N; Springer S; Trowsdale J; Koch N
    J Biol Chem; 2014 Jan; 289(2):639-53. PubMed ID: 24214983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sea bass (Dicentrarchus labrax) invariant chain and class II major histocompatibility complex: sequencing and structural analysis using 3D homology modelling.
    Silva DS; Reis MI; Nascimento DS; do Vale A; Pereira PJ; dos Santos NM
    Mol Immunol; 2007 Jul; 44(15):3758-76. PubMed ID: 17512596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal amino acid sequence analyses of the alpha and beta polypeptides from four distinct subsets of sheep major histocompatibility complex class II molecules.
    Puri NK; Walker ID; Brandon MR
    J Immunol; 1987 Nov; 139(9):2996-3002. PubMed ID: 3478413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early events in the assembly of major histocompatibility complex class II heterotrimers from their free subunits.
    Nijenhuis M; Neefjes J
    Eur J Immunol; 1994 Jan; 24(1):247-56. PubMed ID: 8020564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stoichiometry of HLA class II-invariant chain oligomers.
    Koch N; Zacharias M; König A; Temme S; Neumann J; Springer S
    PLoS One; 2011 Feb; 6(2):e17257. PubMed ID: 21364959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A revised model for invariant chain-mediated assembly of MHC class II peptide receptors.
    Koch N; McLellan AD; Neumann J
    Trends Biochem Sci; 2007 Dec; 32(12):532-7. PubMed ID: 17980601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC II and the endocytic pathway: regulation by invariant chain.
    Landsverk OJ; Bakke O; Gregers TF
    Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.